Fuji Pharma Co., Ltd. (TYO:4554)
Japan · Delayed Price · Currency is JPY 2,339.00
+48.00 (2.10%)
May 29, 2026, 3:30 PM JST
Fuji Pharma Market Cap
Fuji Pharma has a market cap or net worth of 61.09 billion as of May 29, 2026. Its market cap has increased by 84.30% in one year.
Market Cap
61.09B
Enterprise Value
79.83B
Revenue
57.30B
Ranking
n/a
PE Ratio
23.74
Stock Price
2,339.00
Market Cap Chart
Since December 21, 2005, Fuji Pharma's market cap has increased from 17.38B to 61.09B, an increase of 251.43%. That is a compound annual growth rate of 6.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 60.08B | 30.12% |
| Dec 30, 2025 | 46.17B | 18.77% |
| Dec 30, 2024 | 38.88B | -8.01% |
| Dec 29, 2023 | 42.26B | 70.05% |
| Dec 30, 2022 | 24.85B | -0.36% |
| Dec 30, 2021 | 24.94B | -35.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Towa Pharmaceutical | 192.73B |
| Kissei Pharmaceutical | 166.22B |
| Kaken Pharmaceutical | 153.93B |
| Mochida Pharmaceutical | 123.19B |
| Zeria Pharmaceutical | 101.02B |
| ASKA Pharmaceutical Holdings | 84.54B |
| KYORIN Pharmaceutical | 73.88B |
| Daito Pharmaceutical | 35.15B |